FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:22:44.566Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
Product / business disclosures (FY 2026)
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Sterilization and Disinfection Control$101.57M
Calibration Solutions$53.55M
Biopharmaceutical Development$48.63M
Clinical Genomics$45.39M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Reviewed labels link to their filing; other labels are unverified FMP source labels.
UNITED STATES$116.89M
Other$111.79M
CHINA$20.45M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$60.14M
vs Estimate
$60.87M
Missed
MLAB Analyst Ratings
Consensus Rating
Buy
Based on 1 analyst
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Average Price Target
$125.00
-8.1% downside
Low
$125.00
Current
$136.06
High
$125.00
MLAB Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Sep 2026
$2.27
$2.29
$2.31
1
Quarter ending Dec 2026
$2.74
$2.77
$2.79
1
Quarter ending Mar 2027
$2.57
$2.60
$2.62
1
Quarter ending Jun 2027
$2.51
$2.53
$2.55
1
Annual
Period
Low
Avg
High
# Analysts
FY 2027
$10.02
$10.19
$10.36
1
FY 2028
$10.70
$10.88
$11.07
1
Revenue Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Sep 2026
$60.60M
$62.20M
$63.80M
2
Quarter ending Dec 2026
$65.50M
$65.95M
$66.40M
2
Quarter ending Mar 2027
$65.70M
$66.15M
$66.60M
1
Quarter ending Jun 2027
$61.58M
$62.00M
$62.42M
1
Annual
Period
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
